Literature DB >> 2565586

Neuroleptic-induced akathisia: a review.

L A Adler1, B Angrist, S Reiter, J Rotrosen.   

Abstract

Neuroleptic-induced akathisia (NIA) is a relatively common side effect of neuroleptics, in which patients complain of a subjective sense of restlessness usually referable to the legs and have characteristic motor movements. This paper will review: 1) history of spontaneously occurring syndromes of pathologic restlessness and NIA, 2) the clinical significance of NIA, 3) issues concerning the diagnosis and quantification of NIA, 4) treatments of NIA and 5) possible future directions for research in this area. Special attention will be paid to newer treatments for this syndrome, specifically beta-blockers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565586     DOI: 10.1007/BF00443404

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

1.  Comparison between akathisia developing on treatment with phenothiazine derivatives and the restless legs syndrome.

Authors:  S BLOM; K A EKBOM
Journal:  Acta Med Scand       Date:  1961-12

2.  Pseudoparkinsonism and tardive dyskinesia.

Authors:  G E Crane
Journal:  Arch Neurol       Date:  1972-11

Review 3.  The clinical importance of cardioselectivity and lipophilicity in beta blockers.

Authors:  J M Cruickshank
Journal:  Am Heart J       Date:  1980-08       Impact factor: 4.749

4.  Efficacy of propranolol in neuroleptic-induced akathesia.

Authors:  L Adler; B Angrist; E Peselow; J Corwin; J Rotrosen
Journal:  J Clin Psychopharmacol       Date:  1985-06       Impact factor: 3.153

5.  Factors related to tardive dyskinesia.

Authors:  G Chouinard; L Annable; A Ross-Chouinard; J N Nestoros
Journal:  Am J Psychiatry       Date:  1979-01       Impact factor: 18.112

6.  Treatment of akathisia with lorazepam. An open clinical trial.

Authors:  M Bartels; K Heide; K Mann; H W Schied
Journal:  Pharmacopsychiatry       Date:  1987-03       Impact factor: 5.788

7.  Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.

Authors:  W M Braude; T R Barnes; S M Gore
Journal:  Br J Psychiatry       Date:  1983-08       Impact factor: 9.319

8.  Late-onset akathisia--an indicant of covert dyskinesia: two case reports.

Authors:  W M Braude; T R Barnes
Journal:  Am J Psychiatry       Date:  1983-05       Impact factor: 18.112

9.  The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms.

Authors:  D S Charney; D E Sternberg; H D Kleber; G R Heninger; D E Redmond
Journal:  Arch Gen Psychiatry       Date:  1981-11

10.  A controlled assessment of propranolol in the treatment of neuroleptic-induced akathisia.

Authors:  L Adler; B Angrist; E Peselow; J Corwin; R Maslansky; J Rotrosen
Journal:  Br J Psychiatry       Date:  1986-07       Impact factor: 9.319

View more
  17 in total

1.  Antipsychotic-induced movement disorders: evaluation and treatment.

Authors:  Maju Mathews; Sylvia Gratz; Babatunde Adetunji; Vinu George; Manu Mathews; Biju Basil
Journal:  Psychiatry (Edgmont)       Date:  2005-03

2.  Pharmacokinetics of raclopride formulations. Influence of prolactin and tolerability in healthy male volunteers.

Authors:  G Movin-Osswald; A L Nordström; M Hammarlund-Udenaes; A Wahlén; L Farde
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

3.  Neuroleptic-induced akathisia: a role for MSH peptides.

Authors:  R Sandyk
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 4.  Research diagnostic criteria for drug-induced akathisia: conceptualization, rationale and proposal.

Authors:  P Sachdev
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

Review 5.  Adverse effects of antipsychotic drugs.

Authors:  A K Malhotra; R E Litman; D Pickar
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606

6.  Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions.

Authors:  P E Holtom; P L Needham; G W Bennett; S Aspley
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

7.  Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.

Authors:  H Lublin; J Gerlach; L Peacock
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  Pitfalls and problems of the long term use of neuroleptic drugs in schizophrenia.

Authors:  M F Bristow; S R Hirsch
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

9.  Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride.

Authors:  L Farde
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 10.  A clinical guide to antipsychotic drugs.

Authors:  J T Schwartz; A W Brotman
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.